In the original article, there was a mistake in Figure 2 as published. 1. Figure 2A (left) missed to indicate the corresponding groups for the panels. The corresponding groups are now correctly indicated. 2. Figure 2B: The representative flow cytometry plot was repeated two times (same flow cytometry image shown in the third column). The flow cytometry image are the results of flow cytometry detection of anti-CD86-PC7 in the Me49 group.We replaced the lower flow cytometry image in the third column with a representative flow-cytometry plot of anti-CD206-APC in the Me49 group. The corrected Figure 2 appears below.
Figure 2
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Toxoplasma gondii, dendritic cells, exosome, miRNA, macrophage, miR-155-5p
Citation
Zhu S, Lu J, Lin Z, Abuzeid AMI, Chen X, Zhuang T, Gong H, Mi R, Huang Y, Chen Z and Li G (2022) Corrigendum: Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer. Front. Oncol. 12:927917. doi: 10.3389/fonc.2022.927917
Received
25 April 2022
Accepted
31 May 2022
Published
21 June 2022
Volume
12 - 2022
Edited and reviewed by
Anil Shanker, Meharry Medical College, United States
Updates
Copyright
© 2022 Zhu, Lu, Lin, Abuzeid, Chen, Zhuang, Gong, Mi, Huang, Chen and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guoqing Li, gqli@scau.edu.cn; Zhaoguo Chen, zhaoguochen@shvri.ac.cn; Zhibing Lin, mdzhibing@163.com
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.